July 1, 2009
Biogen Idec and Acorda Therapeutics Announce Collaboration Agreement to Develop and Commercialize MS Therapy Fampridine-SR in Markets Outside the U.S.
June 8, 2009
Acorda Therapeutics Announces Eligibility of Fampridine-SR for Centralized Review in Europe
privacy policy
|
terms of use
| Copyright© 2004-2006 Acorda Therapeutics Inc. All rights reserved
